Health

Defence is not an easy industry to operate or invest in, but RTX Ventures' Dan Ateya lays out how they help startups navigate it.

How do you stop AI from being racist? What if you could diagnose autism at birth using a single strand of hair? Here are 10 spinouts doing this and more.

Tech's greatest deal had been YouTube by Sequoia but the venture model has evolved with founder ambitions

Corporate-backed VC deals fell just 2% in 2022 vs a 25% fall for venture capital overall. A record number of new corporate funds were created.

Sanofi's strategic investment arm received a top up from its pharmceutical parent in a week when it led an $80m round for its latest portfolio company.

Strong internal networks help corporate investment teams get better results. Chad Bown, of BP, and Nicole Lapointe, of Capital One, shared tips on building them.

Synthetic biology, healthier options, sustainability and digitalisation are big themes for the beauty and food industries this year.

Several new corporate venture units have launched in the past few weeks, showing that big business is still committed to startup investing.

Today, 1.3 million people die each year because of antimicrobial resistance, a figure that could increase to 10 million by 2050 — Strathclyde’s Microplate Dx hopes to prevent that.

What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.

The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.